0000103623-24-000021.txt : 20240208
0000103623-24-000021.hdr.sgml : 20240208
20240208163326
ACCESSION NUMBER: 0000103623-24-000021
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Viking Therapeutics, Inc.
CENTRAL INDEX KEY: 0001607678
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 461073877
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-37355
FILM NUMBER: 24609601
BUSINESS ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-704-4660
MAIL ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rouan Sarah Kathryn
CENTRAL INDEX KEY: 0001761366
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
144
1
primary_doc.xml
144
0001761366
XXXXXXXX
LIVE
0001607678
Viking Therapeutics, Inc.
001-37355
9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO
CA
92121
858-704-4660
Rouan Sarah Kathryn
Director
common
Oppenheimer & Co Inc
85 Broad Street
New York
NY
10004
25000
701250.00
1000028953
02/08/2024
NASDAQ
common
07/01/2019
NQSO
Issuer
N
25000
02/08/2024
N/A
N
Sarah Rouan
9920 Pacific Heights Blvd
San Diego
CA
92121
common
01/19/2024
30000
619500.00
sale pursuant to 10b5-1 trading plan dated 5/3/2023 - POA on file
02/08/2024
05/03/2023
Sarah Kathryn Rouan